THR-β agonist 3

• UNSPSC Description:

  THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/thr-β-agonist-3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=C2[C@](C3=CC(C(C)C)=C(C=C3)O)([H])CCC2=CC(OC[P@@]4(O[C@@](C5=CC(Cl)=CC=C5)([H])CCO4)=O)=C1

• Molecular Weight:

  526.99

• References & Citations:

  [1]Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2656400-84-7